Scholar Rock
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Our most advanced investigational product candidate, apitegromab (SRK-015), a
51 - 200 employees
Founded 2016
đź’° $205M Post-IPO Equity on 2022-06
Vice President, Market Access, EMEA
Job not on LinkedIn
October 20
🗣️🇩🇪 German Required
Scholar Rock
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Our most advanced investigational product candidate, apitegromab (SRK-015), a
51 - 200 employees
Founded 2016
đź’° $205M Post-IPO Equity on 2022-06
đź“‹ Description
• Shape and lead value and access submission and negotiation planning, including optimal country launch sequence • Ensure sustainable access in key European markets • Work cross-functionally to influence long-term growth and patient impact, building a global multi-billion company serving patients suffering from rare neuro-muscular diseases • Lead market access launch of apitegromab for spinal muscular atrophy (SMA) starting with Germany • Adapt Global market access strategies and tactics for these markets, including drug distribution, value proposition, pricing, health technology assessment, and economic modeling • Cultivate relationships with key payers and stakeholders who influence payers • Compellingly communicate clinical and economic value of apitegromab to these stakeholders • Lead payer negotiations at the national, regional, and local levels • Manage relevant market access vendors, resources, and budget • Represent EMEA Value & Access on apitegromab Global and Country teams • Effectively communicate insights, strategies, voice of access customers, and implications to leadership
🎯 Requirements
• Degree level required. Advanced degrees (Masters, PhD, etc) in related healthcare fields a plus • At least 15 years’ experience in EMEA or Global Market Access with a deep understanding of evolving EMEA policy, access, coverage, and reimbursement landscape • Experience in German market access is a must • Demonstrated success achieving reimbursement, pricing and launch success for a first-in-class or specialty therapy in European markets (especially Germany, France, Italy) • Deep understanding of Europe payer systems and HTA processes, including JCA, AMNOG and other EU frameworks • Track record of success in working cross-functionally to achieve objectives (Marketing, Medical, HEOR, Finance, Key Account Management/Sales, Policy/Advocacy, etc.) • Ability to adapt Global market access strategies for EMEA: insights, strategy development, pricing & contracting, health technology assessments, early access programs, value proposition, impact on demand and GTN • Relationships with national, regional, and local payers; success in negotiating pricing and reimbursement for rare disease therapies; and strong understanding of evolving decision making, processes/procedures, and data and reporting • Neuromuscular and hospital-administered/infusion experience preferred • Pre-launch experience at a biotechnology company preferred • Strong executive presence, with the ability to clearly articulate complex value stories to both internal and external stakeholders including Pricing Committees • Independent, proactive problem solver with strong written verbal communication skills in German and English.
🏖️ Benefits
• Equal Opportunity Employer • Committed to creating an inclusive environment for all employees
Apply Now